(Q36607424)

15 August 2017

1 reference

title

Endogenous Candida endophthalmitis. (English)

1 reference

15 August 2017

Ahmed Sallam

1

1 reference

15 August 2017

William Lynn

series ordinal

2

1 reference

15 August 2017

Peter McCluskey

series ordinal

3

1 reference

15 August 2017

Sue Lightman

series ordinal

4

1 reference

15 August 2017

publication date

1 August 2006

1 reference

Expert Review of Anti-infective Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

675-685

1 reference

Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Management and outcome of bloodstream infections due to Candida species in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Blood-borne Candida endophthalmitis. A clinical and pathologic study of 21 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Candida glabrata endophthalmitis treated successfully with caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Management of endogenous fungal endophthalmitis with voriconazole and caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Invasive candidiasis in cancer patients: observations from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Unusual etiology of visual loss in an HIV-infected patient due to endogenous endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Ocular involvement in children with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Sequestration and late activation of lenticular Candida abscess in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Successful treatment of fungal retinitis and retinal vasculitis with oral itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Fungal endophthalmitis diagnosis by detection of Candida albicans DNA in intraocular fluid by use of a species-specific polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

The eye in systemic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Patterns of amphotericin B killing kinetics against seven Candida species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Lipid formulations of amphotericin B: clinical efficacy and toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

New lipid formulation of amphotericin B: spectral and microscopic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Mode of action of 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Editorial Commentary: Fluconazole Plus Amphotericin B Combinations Are Not Contraindicated and May Add Benefit for the Treatment of Candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Biodegradable scleral implant for intravitreal controlled release of fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Voriconazole: a new triazole antifungal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Intravitreal voriconazole: an electroretinographic and histopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Ocular and systemic posaconazole(SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Anidulafungin: a novel echinocandin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Visual and anatomical outcome following submacular surgery for choroidal neovascularization secondary to Candida endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Anatomic results and complications in a long-term follow-up of pneumatic retinopexy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Candida albicansEndophthalmitis in Brown Heroin Addicts: Response to Early Vitrectomy Preceded and Followed by Antifungal Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

21 January 2018

New antifungal agents

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

Candidemia in intensive care unit patients: Risk factors for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.4.675

21 January 2018

Identifiers

DOI

10.1586/14787210.4.4.675

1 reference

15 August 2017

1 reference